Eight Roads is a global venture capital firm, established in 1969, that invests in technology and healthcare companies across Asia, Europe, Israel, and the United States. It manages over $11 billion in assets through various funds, including Eight Roads Ventures China, Europe, India, and Japan. The firm focuses on early venture, growth capital, and growth stage investments, typically committing between $1.29 million to $30 million per company. Eight Roads seeks minority and majority stakes, often taking a board seat, and has invested in over 500 companies such as Alibaba, Chewy, and Toast. It operates as the proprietary investment arm of Fidelity International Limited.
Managing Partner, Fidelity International Strategic Ventures
Umang Agarwal
Principal
Sanjay Aggarwal
Venture Partner
Hiroki Ashida
Vice President
Daniel Auerbach
Senior Managing Partner, Asia
Vytautas Balsys
Partner
Helena Barman
Investor
Virginia Bassano
Vice President
Shirish Belapure
Venture Partner
Daniel Benjamin
Associate
Betty Cai
Partner
Arvind Chari
Vice President
Ted Chua
Partner
Lucile Cornet
Partner
Kevin Du
Senior Associate
Raj Dugar
Managing Partner, India
Martin Ericsson
Principal
Tamina Fogelberg
Associate
Siddhant Gandhi
Associate
Elaine Gao
Senior Associate
Antonin Gury-Coupier
Vice President
Davor Hebel
Managing Partner and Head of Europe
April Hu
Vice President
Tao Huang
Principal
Tammy Huang
Senior Associate
Tao Huang
Principal
Allen Huo
Vice President
Abhishek Jain
Vice President
Zang Jialun
Partner
Murata Junichi
Principal
Deepak Kanvinde
Venture Partner
Michiko Kohyama
Vice President
Shinichiro Komoto
Partner
Kavish Kothari
Principal
Chintan Kothari
Partner
Thomas Lin
Vice President
Rebecca Lin
Partner
Xin Liu
Partner
Allen Liu
Senior Associate
Maneesh Menon
Principal
Sophie Meralli
Vice President
Chersy Miao
Senior Associate
David Milstein
Managing Partner and Head of Japan
Jens Neisius
Vice President
Dan O'Toole
Vice President
Yosuke Ouchi
Principal
Delphine Qiu
Principal
Eyal Rabinovich
Principal
Laura Salesse
Senior Associate
Fuga Sawada
Senior Associate
Shawn Shen
Partner
Sagar Sheth
Vice President
Lei Shi Ph.D
Partner
Arjun Singh
Senior Associate
Michael Stephanblome
Venture Partner
Liena Suzuki MD
Principal
Aditya Gurunath Systla
Principal
Michael Treskow
Partner
Jarlon Tsang
Managing Partner and Head of China
Ashish Venkataramani
Partner
Ashish Venkataramani
Partner
He Wang
Vice President
Bo Wang
Senior Associate
Nancy Xu
Vice President
Cody Yin Ph.D
Partner
Zhang Yixiao
Executive Director
Yuan Yuan
Principal
Alston Zecha
FinTech and Enterprise Software and Director
Haoming Zhang
Vice President
Gordon Zhang
Vice President and Principal
Feng Zhao
Partner
Weimin Liu Ph.D
Partner
Past deals in Series B
UGOKU
Series B in 2025
UGOKU is a provider of management of personal coaching service.
Swan
Series B in 2025
Swan is a European fintech company that specializes in embedded finance, providing an online banking platform for businesses to create and manage their bank accounts. Founded in 2019 and based in Paris, Swan enables companies to integrate banking features, such as accounts, cards, and payments, into their own products through simple APIs. The platform processes over 200 million euros in transactions monthly for more than 60 companies across ten European countries. As a licensed financial institution and a principal member of Mastercard, Swan is regulated by the ACPR. The company was co-founded with the startup studio eFounders and has received growth capital from prominent venture capital investors. Swan is led by a team of fintech experts with extensive industry experience.
Bhanzu
Series B in 2024
Bhanzu is a math-learning platform aimed at fostering interest in math and STEM careers among students of all ages. The platform offers a carefully crafted curriculum that caters to individual learning needs, ensuring a customized educational experience. Bhanzu provides a variety of educational resources, including videos that address common challenges such as math anxiety, particularly for younger learners in grades 1 to 3. By promoting experiential learning and enhancing cognitive abilities, Bhanzu helps students improve their math skills and apply mathematical concepts in real-world situations.
AvenCell
Series B in 2024
Based on our deep science and focused on patients in need.
Everstage
Series B in 2024
Everstage is a no-code commissions automation platform founded in 2020 and based in Wilmington, Delaware. The company focuses on enhancing the performance of customer-facing teams by providing a transparent and gamified incentives experience. Its platform allows businesses to create customized incentive structures while automating repetitive manual tasks. With features that offer real-time visibility and insights into performance, Everstage aims to save Operations and Finance teams time and effort, ultimately motivating employees and driving productivity.
Spry
Series B in 2024
Spry is a digital health platform that enables movement health professionals to collect and analyze patient data in real time. By leveraging machine learning and artificial intelligence, the platform provides personalized protocols based on evidence-based practices and standards of care. This allows practitioners and owners of physical therapy centers to effectively manage both clinical and administrative functions, enhancing the quality of patient care and operational efficiency.
HERO Software
Series B in 2024
HERO Software specializes in cloud-based solutions that enhance office productivity and streamline project management processes for businesses. Its comprehensive platform enables users to digitize the entire workflow, starting from initial client interactions through to invoicing. The HERO application offers a range of features tailored for professionals in the field, including customer and project management, appointment scheduling, construction site documentation, and task management. By facilitating effective communication and improving operational management, HERO Software supports various aspects of a craftsman's operations, allowing for better monitoring of project progress and task completion.
Engrail Therapeutics
Series B in 2024
Engrail Therapeutics, Inc. is dedicated to developing and commercializing neuro drugs aimed at treating diseases of the nervous system. Founded in 2019 and based in San Diego, California, the company focuses on creating transformative medicines to alleviate the significant burden of such conditions. One of its key products is ENX-101, a preclinical compound designed to modulate a receptor for GABA, a critical neurotransmitter in the brain. Engrail Therapeutics combines biological insights with clinically meaningful solutions to advance its portfolio of therapies, utilizing a flexible transaction model to efficiently progress its drug candidates from development to commercialization.
HiLabs
Series B in 2024
HiLabs is a developer of a healthcare data mining platform that aims to enhance data-driven decision-making within healthcare organizations. Recognizing that these organizations possess invaluable domain knowledge, HiLabs provides tools that enable them to harness this expertise alongside their data. The platform employs artificial intelligence to allow healthcare professionals to intuitively explore their data, interact with visualizations, customize dashboards, and generate new attributes. This empowers users to independently uncover novel insights and better understand client health data, ultimately facilitating more effective healthcare management and decision-making.
EurekaBio
Series B in 2024
EurekaBio specializes in developing solutions for cancer immunotherapy, particularly in the realm of cell therapy. The company offers automated manufacturing equipment for cell therapies and a platform for vector production. By focusing on automation in medical equipment related to gene and cell therapy, EurekaBio aims to enhance the accuracy and efficiency of cancer treatments, ultimately benefiting patients in need of innovative therapeutic options.
La Fourche
Series B in 2024
La Fourche is an online retail platform dedicated to making healthy consumption accessible to a broader audience by offering a wide range of organic products at affordable prices. The company operates on a subscription model, providing customers with thousands of organic items at discounts of up to 50%. This approach allows families to significantly reduce their grocery spending, potentially saving up to 1,000 euros annually. La Fourche emphasizes the importance of socially committed and environmentally friendly options, enabling consumers to select from a diverse array of healthy food products while promoting sustainable practices.
Xbit
Venture Round in 2024
Xbit provides a shift management system that assists shop owners in optimizing their business processes. The company's platform includes a chatbot service that enables users to gather employee availability and create efficient shift schedules. By addressing customer needs and implementing effective solutions, Xbit helps clients reduce operational costs while maintaining service quality through proper personnel allocation.
Micoworks
Series B in 2023
Micoworks is a planning and development platform that focuses on enhancing marketing strategies through improved communication. It offers tools designed for optimal communication and personalization of the customer experience. The platform enables businesses to categorize customer information effectively and automates various processes, including customer interviews, conversations, and reservations. This functionality allows clients to streamline their operations and develop their marketing strategies more efficiently.
Exponent Energy
Series B in 2023
Exponent Energy is a start-up dedicated to enhancing electric vehicle (EV) charging through innovative fast charging technology. The company specializes in battery-swapping infrastructure, aiming to provide a more efficient and cost-effective charging solution for EV users. It manufactures an integrated energy stack designed to minimize impedance build-up, which facilitates a smooth energy flow. This system includes a cohesive battery management system, battery pack, and charger that work in unison to streamline the charging process. By focusing on these advancements, Exponent Energy seeks to simplify and accelerate the energy replenishment for electric vehicles, catering to the growing demand for sustainable transportation solutions.
Eleos Health
Series B in 2023
Eleos Health develops innovative health technology solutions aimed at enhancing decision-making for clinicians in the behavioral health sector. The company's AI-powered Speech-to-Insights system operates during mental health sessions to analyze voice data in real time. By gathering insights on patients through this voice technology, Eleos Health enables clinicians to deliver personalized, efficient, and cost-effective care. The automated nature of the system helps streamline the clinical process, ultimately supporting mental health professionals in providing the necessary care and support for their patients.
Sonosemi Medical
Series B in 2023
Sonosemi Medical is a provider of medical devices that specializes in the development of pan-vascular active interventional products, diagnosis, and treatment solutions.
La Fourche
Series B in 2023
La Fourche is an online retail platform dedicated to making healthy consumption accessible to a broader audience by offering a wide range of organic products at affordable prices. The company operates on a subscription model, providing customers with thousands of organic items at discounts of up to 50%. This approach allows families to significantly reduce their grocery spending, potentially saving up to 1,000 euros annually. La Fourche emphasizes the importance of socially committed and environmentally friendly options, enabling consumers to select from a diverse array of healthy food products while promoting sustainable practices.
Doceree
Series B in 2023
Doceree Inc is a healthcare marketing technology company that operates a programmatic physician engagement and advertising platform. Founded in 2019 and based in Parsippany, New Jersey, with an additional office in New Delhi, India, Doceree specializes in connecting pharmaceutical and healthcare brands with healthcare professionals (HCPs). The platform enables targeted advertising and provides data analytics to help clients effectively reach and engage with HCPs in a compliant manner. Utilizing artificial intelligence and data segmentation, Doceree identifies specific HCPs across various digital platforms, including physician networking sites, medical journals, and telemedicine platforms. This approach allows healthcare industry professionals to deliver precise and transparent messaging at scale, catering to the needs of media agencies, pharmaceutical brands, medical device companies, consumer healthcare brands, and hospitals.
Cataya Bio
Series B in 2023
Cataya Bio (Shanghai) Co., Ltd. is focused on developing synthetic biological products for diverse industries through its advanced engineering biology platform and biomanufacturing capabilities. The company engineers microbes and creates clean fermentation processes to produce high-purity products sustainably and cost-effectively. By leveraging synthetic biology technology, Cataya Bio enables clients to obtain natural and sustainable raw materials, contributing to a shift away from petroleum-based resources. The company's efforts address critical global challenges such as environmental preservation, carbon emissions, and climate change.
Raft
Series B in 2023
Raft is a logistics platform that leverages artificial intelligence to automate the freight process, providing enhanced control and visibility for operators. By streamlining various tasks such as managing accounts payable invoices, customs documentation, and shipping workflows, Raft significantly reduces the need for manual input and reconciliation. This automation allows freight forwarders and customs brokers to operate more efficiently, saving valuable time and improving accuracy and compliance in their operations. The platform's real-time processing capabilities enable operators to handle shipments promptly and with greater certainty, ultimately enhancing customer service.
K36 Therapeutics
Series B in 2023
K36 Therapeutics is engaged in the development of small molecule therapeutics aimed at treating cancer. The company focuses on translating epigenetic modulation of oncogenic pathways into effective therapies, utilizing technology to create orally bioavailable small molecules and selective inhibitors. This innovative approach enables healthcare professionals to enhance treatment options for cancer patients, addressing the complexities of oncogenic pathways and improving therapeutic outcomes.
SAFE Security
Series B in 2023
SAFE Security, also known as Lucideus Tech Private Limited, is a cyber risk management company headquartered in New Delhi, India. Founded in 2012, it specializes in providing comprehensive information technology risk assessment and digital security services to organizations globally. The company develops a cyber risk quantification and management platform that enables businesses to continuously monitor and respond to cyber threats in real time. SAFE Security's offerings include IT security maturity assessments, governance policy formation, application security, IT infrastructure security, and emergency response services. By establishing a common risk taxonomy, the platform facilitates better communication among stakeholders and shifts the focus of security discussions from tactical projects to strategic value, ultimately helping organizations mitigate cyber risks through prioritized actionable insights.
Canoe
Series B in 2023
Canoe Software Inc. provides a sophisticated software solution focused on financial document and data management. Founded in 2013 and based in New York, the company specializes in automating the extraction and organization of investment documents using artificial intelligence and machine learning technologies. This enables users to efficiently convert unstructured data from various formats, such as PDFs, into actionable insights, thereby improving operational efficiency. Canoe's platform supports a wide range of clients, including single and multi-family offices, endowments, foundations, pensions, investment consultants, and financial institutions, facilitating better management of post-investment operations, monitoring, and reporting. By streamlining the data management process, Canoe helps minimize manual data entry and enhances the accuracy of financial reporting and analysis.
NOCD
Series B in 2023
NOCD Inc. is a Chicago-based company that operates a mobile application designed to connect individuals with obsessive-compulsive disorder (OCD) to licensed mental health practitioners. Founded in 2014, the platform leverages cognitive behavioral therapy techniques, specifically exposure and response prevention exercises, to help users manage their symptoms. The application facilitates face-to-face video therapy sessions with therapists who specialize in OCD, while also providing 24/7 support through self-help tools and peer communities. NOCD aims to enhance the treatment experience for OCD patients by offering clinically supported resources and a comprehensive online platform dedicated to treatment and self-monitoring.
MEIHUAMEDICAL
Series B in 2022
MEIHUAMEDICAL develops, produces and sells microbial medical instruments & diagnostic reagents.
Kaiko
Series B in 2022
Kaiko is a provider of digital asset market data services, offering global connectivity to over 100 centralized and decentralized cryptocurrency exchanges. Its mission is to bridge traditional finance with crypto by delivering actionable financial data through four business units: Market Data, Quantitative Analytics, Indices, and Research. Kaiko empowers various use cases across the investment lifecycle for both investors and enterprises.
EurekaBio
Series B in 2022
EurekaBio specializes in developing solutions for cancer immunotherapy, particularly in the realm of cell therapy. The company offers automated manufacturing equipment for cell therapies and a platform for vector production. By focusing on automation in medical equipment related to gene and cell therapy, EurekaBio aims to enhance the accuracy and efficiency of cancer treatments, ultimately benefiting patients in need of innovative therapeutic options.
Invetx
Series B in 2022
Invetx, Inc. is a biotechnology company focused on developing protein-based therapeutics for animal health care and veterinary medicine. Based in Boston, Massachusetts, Invetx's team comprises veterinary scientists and clinicians dedicated to discovering and creating biotherapeutics for both pets and farm animals. The company aims to enhance health outcomes in the animal health industry by leveraging biopharma technologies, supported by a network of experts in animal and human health. Through its innovative platform, Invetx is committed to advancing a portfolio of therapies and technologies designed to improve animal care and well-being.
eKincare
Series B in 2022
eKincare is an innovative health benefits platform that leverages AI to provide personalized healthcare solutions. Recognized as India’s first personal health assistant, the platform integrates technology and analytics to deliver preventive and predictive health services to organizations and their employees. eKincare offers a variety of online and offline healthcare services, including 24/7 access to medical consultations, health check-ups, medication purchasing and delivery, health coaching, mental wellness programs, and fitness services. By monitoring and gathering medical data from various healthcare providers, the platform enables users to track their health information and identify potential health risks, facilitating timely interventions to enhance overall well-being. Trusted by numerous Fortune 500 companies, eKincare aims to redefine the healthcare experience through a comprehensive and user-friendly approach.
Inceptio Technology
Series B in 2022
Inceptio Technology, founded in 2018 and based in Shanghai, China, specializes in the development of autonomous driving trucks aimed at transforming line-haul logistics. The company offers a nationwide freight network and provides a Transportation-As-A-Service model that enhances the security, efficiency, and cost-effectiveness of logistics operations. Utilizing advanced technologies such as artificial intelligence, new energy solutions, and logistics big data, Inceptio's heavy-duty trucks deliver innovative and safe logistics solutions tailored for logistics companies. Additionally, the company has established research and development centers in both Shanghai and Silicon Valley to further its technological advancements.
Saas Labs
Series B in 2022
SaaS Labs is a developer of cloud-based solutions focused on enhancing communication and marketing efficiency for businesses. Their primary product is a phone system that allows users to make and receive calls from a computer, web browser, or desktop, facilitating seamless communication from any location. The system enables users to acquire virtual phone numbers in various countries and start making calls or sending texts within minutes. Additionally, it offers features for setting up call centers, tracking calls, and accessing call recordings, all of which contribute to improved productivity for sales teams. Beyond communication tools, SaaS Labs also develops marketing products aimed at increasing brand visibility.
Mention Me
Series B in 2022
Mention Me Limited operates a software-as-a-service platform that specializes in referral marketing for online businesses. Since its incorporation in 2013 and headquartered in London, the company assists brands in leveraging customer advocacy through its unique Referral Engineering approach, which has generated over 4.5 million referrals and approximately $1.5 billion in revenue for a diverse range of clients, including notable names like Charlotte Tilbury and Puma. The platform enables businesses to implement refer-a-friend programs, rewarding both referrers and new customers, while also facilitating social sharing through email and social media. Mention Me offers features such as A/B testing for campaign optimization, real-time results via a referral dashboard, and insights for performance enhancement. The company has built a growing partner network that includes platforms like Emarsys and Klaviyo and has secured $32 million in funding since 2018 to support its expansion.
Juro
Series B in 2022
Juro is a technology company that specializes in contract automation. It offers a platform that enables businesses to create, execute, and manage contracts more efficiently using artificial intelligence and machine learning. By integrating with existing systems, Juro helps legal and business teams agree on contracts up to 10 times faster than traditional tools. The company works with prominent clients such as Trustpilot, WeWork, and Deliveroo, serving over 6000 companies across 85 countries. Juro has raised $32 million in venture capital from investors including Fidelity, USV, and the founders of Indeed, Wise, and Gumtree.
Thinksurance
Funding Round in 2022
Thinksurance GmbH is a technology-driven insurance brokerage based in Frankfurt am Main, Germany, specializing in commercial insurance for small and medium-sized enterprises. Founded in 2014, the company offers a comprehensive range of insurance products, including various forms of craft and trade insurance, as well as specialized coverage for founders and freelancers. Thinksurance operates an online platform that connects insurers, brokers, and business customers, facilitating the comparison and procurement of suitable insurance policies. The platform is designed to streamline the distribution process through the use of proprietary technology and APIs that integrate with the systems of insurers and distributors. Additionally, Thinksurance provides consulting services, data analytics, and other support to enhance the effectiveness of insurance distribution. The company also runs an online brokerage portal, Gewerbeversicherung24, to gather direct feedback from businesses, helping to refine and improve the services offered to its partners.
Leocare
Series B in 2021
Leocare Assurance is an insurance company that provides a range of multi-equipment contracts, focusing on the design, distribution, and management of various insurance products. Its platform caters to clients by offering insurance solutions for auto and housing needs, as well as digital assets. By combining protection with savings, Leocare aims to meet the diverse requirements of its customers while ensuring a seamless experience in managing their insurance products.
Lighthouse
Series B in 2021
Lighthouse is a commercial platform tailored for the travel and hospitality industry, specializing in hotel management solutions. The company offers a cloud-based platform that visualizes and leverages data to enhance business success. By providing actionable market insights and business intelligence tools, Lighthouse enables hoteliers and hotel management companies to make informed revenue and distribution decisions. Its services include real-time data analytics, which empower users to maximize property occupancy rates and increase revenue and profit. Formerly known as OTA Insight, Lighthouse aims to transform complex market dynamics into manageable strategies that foster growth in the hospitality sector.
TenaFe
Series B in 2021
TenaFe, Inc. is a technology company that specializes in the development of solid-state drive (SSD) controllers aimed at enhancing data storage solutions across various platforms, including client devices, data centers, and emerging edge applications. Founded in 2018 and based in Campbell, California, TenaFe leverages its patented technology to deliver SSDs characterized by exceptional reliability, performance, and energy efficiency. These innovations serve a diverse array of devices, from connected gadgets and personal computers to large-scale data center operations, ultimately improving storage reliability and energy consumption for its clients.
OriGynMED
Series B in 2021
OriGynMED provides deep professional resources for the invested companies through its global ecosystem to help the business development of the companies. It is a technology-based medical company.
LeadIQ
Series B in 2021
LeadIQ, Inc. is a company that specializes in sales prospecting automation, offering tools designed to enhance lead management and sales productivity. Its main products include Prospector, which enables users to search for prospects on LinkedIn and other platforms while saving the information in CRM systems, and Scout, which helps find contact details directly from company websites. Additionally, LeadIQ provides personal intelligence APIs that allow for the comprehensive profiling of individuals, including their email, phone numbers, and job information. Founded in 2015 and headquartered in South San Francisco, California, with additional offices in Singapore and New Hampshire, LeadIQ aims to streamline the lead capture process, allowing sales teams to focus on high-quality leads and ultimately drive business growth. The platform integrates with various data sources to enrich profiles, reducing time spent on unqualified leads and enhancing sales efficiency.
Jiffy.ai
Venture Round in 2021
Jiffy.ai is a software company that provides an AI-powered platform designed for modern digital enterprises. It specializes in automating tasks through intelligent robots capable of adapting to changing scenarios, thereby enhancing productivity and allowing organizations to focus on more value-added activities. The platform effectively processes unstructured data and employs natural language processing and machine learning algorithms, enabling high levels of automation—often exceeding 90%—in complex processes. Unlike traditional robotic process automation solutions that are primarily rule-based and limited in their automation capabilities, Jiffy.ai's platform offers a comprehensive suite of tools for various functions, including finance, operations, and analytics. This integrated approach allows enterprises to streamline their operations while benefiting from features such as drag-and-drop functionality and reporting automation.
NOCD
Series B in 2021
NOCD Inc. is a Chicago-based company that operates a mobile application designed to connect individuals with obsessive-compulsive disorder (OCD) to licensed mental health practitioners. Founded in 2014, the platform leverages cognitive behavioral therapy techniques, specifically exposure and response prevention exercises, to help users manage their symptoms. The application facilitates face-to-face video therapy sessions with therapists who specialize in OCD, while also providing 24/7 support through self-help tools and peer communities. NOCD aims to enhance the treatment experience for OCD patients by offering clinically supported resources and a comprehensive online platform dedicated to treatment and self-monitoring.
GYENNO Technologies
Series B in 2021
GYENNO Technologies is a digital health company developing medical devices for people with disabilities. GYENNO's products include GYENNO spoon, which helps people with hand tremors eat without stress, and the GYENNO matrix, a wearable motion and gait quantitative evaluation system for Parkinson's disease.
Innovusion
Series B in 2021
Innovusion, Inc. is a developer of advanced image grade LiDAR sensor systems tailored for level 4 and 5 autonomous vehicles and advanced driver-assistance systems (ADAS). Founded in 2016 and based in Sunnyvale, California, the company focuses on delivering high-performance perception solutions that combine range, resolution, and hardware-accelerated sensor fusion. Their compact sensor systems are designed for ease of integration and cost-effectiveness, making them suitable for demanding applications in the autonomous driving market. Innovusion's innovative technology positions it as a key player in the rapidly evolving landscape of autonomous transportation.
Toothsi
Series B in 2021
Toothsi is a dental company that offers clear aligners, an alternative to traditional braces, to gradually shift teeth into proper alignment. Toothsi's aligners are removable, invisible, and more comfortable than metal braces. Toothsi also provides oral hygiene products, teeth whitening solutions, and aligner accessories for complete oral care.
Inceptio Technology
Series B in 2021
Inceptio Technology, founded in 2018 and based in Shanghai, China, specializes in the development of autonomous driving trucks aimed at transforming line-haul logistics. The company offers a nationwide freight network and provides a Transportation-As-A-Service model that enhances the security, efficiency, and cost-effectiveness of logistics operations. Utilizing advanced technologies such as artificial intelligence, new energy solutions, and logistics big data, Inceptio's heavy-duty trucks deliver innovative and safe logistics solutions tailored for logistics companies. Additionally, the company has established research and development centers in both Shanghai and Silicon Valley to further its technological advancements.
Blueglass Yogurt
Series B in 2021
Blueglass Yogurt is a food and beverage brand based in China that specializes in producing and selling a diverse range of yogurt-based products. The company's offerings include various categories such as signature fancy yogurt, fruit yogurt, yogurt salads, cakes, and ice cream. By operating its own stores, Blueglass Yogurt ensures that customers enjoy freshly made yogurt, enhancing the overall consumer experience. The brand aims to cater to the tastes of domestic consumers by providing high-quality yogurt products in a variety of formats, including beverages and desserts.
Castor
Series B in 2021
Castor is an international health-tech company that provides a cloud-based clinical data platform designed to streamline the clinical trial process for researchers globally. Founded by CEO Derk Arts, MD, Ph.D., the platform is utilized by over 50,000 researchers in 90 countries, supporting more than 4,000 studies across diverse therapeutic areas, including diabetes, cardiovascular disease, rare diseases, infectious diseases, and oncology. Castor's platform facilitates the collection and analysis of extensive data from both traditional and remote trials, having reached significant milestones such as 180 million data points and 2 million enrolled patients. The company's mission is to make research data reusable, thereby enabling AI-driven clinical trials and enhancing the overall impact of data within the medical research community.
Quizizz
Series B in 2021
Quizizz Inc. is an educational technology company based in Palo Alto, California, founded in 2015. It offers a mobile application designed to facilitate the creation, review, and assessment of quizzes. The platform supports engaging, gamified quizzes and interactive lessons, making it suitable for both in-person and remote learning environments. Quizizz allows teachers to generate quizzes and enables students to participate in multiplayer classroom activities, fostering collaborative learning. With over 20 million users monthly, including educators, students, and parents, Quizizz provides instant assessment tools that eliminate the need for manual grading, thereby streamlining the educational process. The platform also offers features such as presentations, polls, and comprehensive assessment reports, making it a versatile resource for schools, homes, and training professionals worldwide.
Patient 21
Series B in 2021
Patient21 operates a health platform focused on improving the doctor-patient connection, which they view as essential for effective healthcare. The company aims to modernize the healthcare experience by addressing the fragmented and outdated processes currently prevalent in the industry. By leveraging technology, Patient21 enhances dental clinics with management software that streamlines administrative tasks such as appointment scheduling and patient data management. They also provide electronic health records (EHR) to healthcare professionals, which helps improve diagnostic quality and reduce costs. Through these innovations, Patient21 seeks to facilitate better decision-making for both patients and physicians, ultimately promoting a more personalized and collaborative approach to healthcare.
Smol
Series B in 2021
Smol is a homecare startup that specializes in delivering eco-friendly laundry capsules and dishwasher tablets directly to consumers’ homes through a subscription service. The products are designed to fit through letterboxes, making them convenient and accessible. Smol's offerings are made from recycled materials and are water-soluble, ensuring effective cleaning while minimizing environmental impact. The company emphasizes its commitment to sustainability by using no animal testing or animal-derived ingredients, making its products suitable for vegans. By providing an affordable alternative to leading brands, Smol aims to revolutionize the household cleaning market with its eco-conscious approach.
Proximie
Series B in 2021
Proximie Inc. is a health technology company based in Bedford, Massachusetts, that specializes in a telehealth platform designed for virtual surgical assistance. Founded in 2016 by Nadine Hachach-Haram, Proximie's platform enables surgeons to remotely observe and guide complex surgical procedures using augmented reality, artificial intelligence, and machine learning. This technology allows expert surgeons to connect with their peers globally, sharing knowledge and skills in real-time, regardless of their physical location. The platform is adaptable, compatible with various devices and software used in operating rooms, and can function effectively even in low bandwidth environments. Proximie aims to enhance surgical practices by democratizing access to expert guidance and fostering collaboration among medical professionals.
B-One
Series B in 2021
B-One Ortho Corp. is a manufacturer of orthopedic healthcare solutions, specializing in artificial joints that facilitate joint replacement surgeries. Founded in 2015 and headquartered in Cedar Knolls, New Jersey, the company also maintains offices in Shanghai and Suzhou, China. Its notable products include the B-One total hip system, which features advanced coating technology and instrumentation, as well as the Juveno bone-conserving femoral prosthesis and primary acetabular systems. These innovations aim to enhance the effectiveness of hip and knee arthroplasty, ultimately helping patients regain their mobility and improve their quality of life.
OZiva
Series B in 2021
OZiva is a plant-based clean nutrition brand that specializes in fitness, hair, skin, men's health, women's health, and general wellness products. The brand focuses on creating a nutrition and fitness ecosystem that integrates ancient Ayurvedic principles with modern micronutrient science. By providing organic nutritional products, OZiva aims to assist individuals in making healthier lifestyle choices through effective dietary planning. Their offerings are designed to meet everyday nutritional needs, making it easier for customers to pursue healthy living. The company emphasizes convenience and accessibility, fostering a community that supports its users in their wellness journeys.
Innovusion
Series B in 2021
Innovusion, Inc. is a developer of advanced image grade LiDAR sensor systems tailored for level 4 and 5 autonomous vehicles and advanced driver-assistance systems (ADAS). Founded in 2016 and based in Sunnyvale, California, the company focuses on delivering high-performance perception solutions that combine range, resolution, and hardware-accelerated sensor fusion. Their compact sensor systems are designed for ease of integration and cost-effectiveness, making them suitable for demanding applications in the autonomous driving market. Innovusion's innovative technology positions it as a key player in the rapidly evolving landscape of autonomous transportation.
LakeShore Biopharma
Series B in 2021
Yisheng Biopharma Co., Ltd. is a biopharmaceutical company focused on the research, development, manufacturing, and marketing of immuno-oncology products and vaccines. Founded in 2002 and headquartered in Beijing, the company operates in China, the United States, Cambodia, and Singapore. Yisheng Biopharma utilizes its novel PIKA immunomodulating technology to enhance immune responses against cancers and infectious diseases. Key products under development include YS-ON-001, an investigational therapy aimed at treating advanced solid tumors, as well as YS-HBV-001, a vaccine for hepatitis B, and a PIKA-based rabies vaccine designed for rapid protection against rabies infection. The company's innovative approach targets multiple immune pathways to improve treatment outcomes.
Metcela
Series B in 2021
Metcela Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for cardiac diseases. Founded in 2016 and based in Kawasaki, Japan, Metcela specializes in fibroblast-based treatments, particularly its lead asset, MTC001. This therapy utilizes VCAM-1-positive Cardiac Fibroblasts, which are derived from the patient's own heart cells. Rather than replacing damaged cells, the therapy enhances the body's natural healing processes to repair heart tissue and restore a favorable microenvironment. Through its research and development efforts, Metcela aims to offer patients an effective and affordable alternative for treating heart failure.
OriGynMED
Series B in 2020
OriGynMED provides deep professional resources for the invested companies through its global ecosystem to help the business development of the companies. It is a technology-based medical company.
HiBob
Series B in 2020
HiBob Inc. is a developer of a cloud-based human resources management system designed to modernize HR technology for contemporary workplaces. Founded in 2015 and headquartered in Tel Aviv, Israel, with additional offices in New York and London, HiBob offers its flagship product, Bob, which serves as an integrated human resource information system. This platform facilitates various HR functions, including attendance tracking, time-off management, employee records, compensation management, and performance evaluation. With an intuitive, data-driven design, Bob is tailored for the needs of globally distributed and collaborative work environments. Since its launch, HiBob has experienced significant growth and has become the preferred HRIS for over 1,000 midsize and multinational companies, helping them enhance employee engagement and retention through effective talent management.
Tibber
Series B in 2020
Tibber is a European digital electricity supplier established in 2016, operating in Norway, Sweden, and Germany. It specializes in providing smart, sustainable energy solutions to households, aiming to reduce residential electricity consumption by 20%. Tibber replaces traditional utilities with innovative technology, offering renewable energy at fair and transparent prices. Its user-friendly app provides real-time energy usage analytics and integrates with various smart home devices to help customers minimize their consumption and costs. Additionally, Tibber sells energy-efficient tech gadgets and has been licensed to balance the main power grid in Sweden using electric vehicles.
Odaseva
Series B in 2020
Odaseva is a company that specializes in data management solutions for large enterprises using Salesforce. Its platform provides comprehensive data governance that focuses on data protection, privacy, and operational efficiency. Key features include backup and recovery, archiving, monitoring of governor limits, and compliance with regulatory requirements such as GDPR. Odaseva's tools enable businesses to manage their Salesforce data effectively, ensuring its confidentiality, integrity, and availability. By offering a range of integrated security products and services, Odaseva empowers organizations to take full control of their data, mitigate risks, and accelerate their digital transformation initiatives.
Planck
Series B in 2020
Planck is a commercial insurance data platform that empowers insurers to underwrite businesses with speed and accuracy. Utilizing artificial intelligence, Planck aggregates extensive datasets to provide real-time analytics and insights tailored to the commercial underwriting process. The platform enhances efficiency by pre-filling most responses in ACORD forms, minimizing errors and mitigating fraud, which helps to lower loss ratios. By leveraging publicly available data, image processing, and company reports, Planck enables insurance providers to conduct thorough risk assessments and develop customized insurance policies, ultimately streamlining the underwriting process.
Medallia Digital Experience Analytics
Series B in 2020
Decibel Insight Limited offers an online platform designed to analyze user behavior on websites and applications, helping enterprise businesses enhance the customer experience at various digital touchpoints. The company utilizes machine learning technology to process a wide array of behavioral metrics, such as mouse movements and error occurrences, providing insights through features like heatmaps, session replays, form analytics, and detailed performance reports. Decibel's solutions, available both on-premise and as Software as a Service (SaaS), cater to industries including eCommerce, finance, media, and travel. Established in 2013 and headquartered in London, with additional offices in Denver and Boston, Decibel serves major brands like Lego, General Motors, and British Airways, enabling them to identify opportunities for improvement and foster a customer-centric approach within their organizations.
Otrium
Series B in 2020
Otrium operates a shop-in-shop outlet platform that addresses the issue of unsold inventory in the fashion industry. By partnering with over 300 brands, including emerging designers and luxury names, Otrium provides a marketplace for men’s and women’s fashion clothing at discounted rates. The platform boasts more than 3 million shopping members and offers services such as next-day delivery and quick returns, making it a convenient option for customers seeking the latest styles at competitive prices. Through its data-driven approach, Otrium is reshaping the retail landscape by efficiently connecting brands and consumers while reducing excess stock.
Fenbeitong
Series B in 2020
Fenbeitong is a corporate wallet application designed to streamline the management of corporate expenditures. The platform enables users to oversee, pay, and receive reimbursements for various business-related expenses, such as travel and procurement. By implementing intelligent control rules and reminder measures, Fenbeitong assists enterprises in significantly reducing costs associated with public consumption. Its credit monthly payment and unified invoice consumption model provide employees with a convenient way to manage expenditures without the burden of reimbursement processes, thus enhancing operational efficiency. Overall, Fenbeitong focuses on improving the financial management of corporate spending while facilitating a more efficient workflow for businesses.
Funnel
Series B in 2020
Funnel is a marketing analytics and reporting software that aims to streamline data collection for online advertisers and e-commerce companies. Founded in 2014 by Fredrik Skantze and Per Made, the company provides a platform that integrates with over 400 marketing and advertising sources. This allows businesses to automatically collect and structure advertising performance data, facilitating better decision-making regarding advertising spend and business growth. Funnel enables users to feed data into various tools, including Business Intelligence platforms, Data Warehouses, and visualization tools like Google Data Studio and Google Analytics. The company serves a diverse clientele, including e-commerce businesses, media agencies, brands, B2B enterprises, mobile applications, and gaming companies. Funnel operates from its headquarters in Stockholm, with an additional office in Boston.
Oviva
Series B in 2020
Oviva UK Limited is a healthcare company based in London that specializes in digitally-enabled behavior change programs focused on diet and lifestyle-related health conditions, particularly type 2 diabetes and obesity. Founded in 2015, Oviva has developed a unique platform that combines a smartphone app and learning portals to provide personalized coaching and nutritional advice. This approach allows patients to engage in behavior change without the need for in-person clinic visits, thereby improving health outcomes and reducing costs for healthcare systems by preventing complications associated with these conditions. By leveraging a network of qualified consultants, Oviva aims to support individuals in achieving better health through tailored interventions.
Gloat
Series B in 2019
Gloat is an innovative Internal Talent Marketplace that helps organizations optimize their workforce by connecting employees with suitable internal career opportunities based on their skills and career aspirations. The platform leverages artificial intelligence to provide real-time, personalized career recommendations while maintaining user anonymity. This approach allows individuals to make informed, data-driven career decisions and assists managers in identifying the best candidates for various roles. Gloat is utilized by prominent companies globally, including Unilever, PepsiCo, and HSBC, and operates in over 120 countries, enhancing organizational agility and providing valuable insights into talent management.
CredR
Series B in 2019
CredR operates as an online marketplace dedicated to the buying and selling of pre-owned two-wheeler vehicles in India. The company aims to bring structure to the unorganized second-hand vehicle market, which often suffers from inconsistent pricing and unsatisfactory user experiences. By utilizing a dynamic pricing algorithm, CredR evaluates various factors such as vehicle condition, seasonality, and demand to set competitive prices. Additionally, the platform offers after-sales services and a bike rental option, making it easier for users to access two-wheelers as needed. Through its verified and certified marketplace, CredR simplifies the transaction process, providing a more transparent and convenient experience for both buyers and sellers.
ForceClouds
Series B in 2019
ForceClouds specializes in developing enterprise software designed to enhance information automation in a simple, safe, and efficient manner. The company's software incorporates custom integration capabilities that facilitate the optimization of sales management, clinical trials, and big data and artificial intelligence processes. By doing so, ForceClouds enables large life sciences companies to derive actionable insights from their process data, thereby improving decision-making and operational efficiency.
Medallia Digital Experience Analytics
Series B in 2019
Decibel Insight Limited offers an online platform designed to analyze user behavior on websites and applications, helping enterprise businesses enhance the customer experience at various digital touchpoints. The company utilizes machine learning technology to process a wide array of behavioral metrics, such as mouse movements and error occurrences, providing insights through features like heatmaps, session replays, form analytics, and detailed performance reports. Decibel's solutions, available both on-premise and as Software as a Service (SaaS), cater to industries including eCommerce, finance, media, and travel. Established in 2013 and headquartered in London, with additional offices in Denver and Boston, Decibel serves major brands like Lego, General Motors, and British Airways, enabling them to identify opportunities for improvement and foster a customer-centric approach within their organizations.
Hedone
Series B in 2019
Hedone is an e-commerce platform based in Shanghai, China, specializing in beauty and makeup products. Founded in 2014, the company primarily targets Chinese millennials, offering a range of fashion and beauty items that cater to their individual identities and preferences. By focusing on this demographic, Hedone aims to resonate with younger consumers seeking products that reflect their personal style.
Thinksurance
Series B in 2019
Thinksurance GmbH is a technology-driven insurance brokerage based in Frankfurt am Main, Germany, specializing in commercial insurance for small and medium-sized enterprises. Founded in 2014, the company offers a comprehensive range of insurance products, including various forms of craft and trade insurance, as well as specialized coverage for founders and freelancers. Thinksurance operates an online platform that connects insurers, brokers, and business customers, facilitating the comparison and procurement of suitable insurance policies. The platform is designed to streamline the distribution process through the use of proprietary technology and APIs that integrate with the systems of insurers and distributors. Additionally, Thinksurance provides consulting services, data analytics, and other support to enhance the effectiveness of insurance distribution. The company also runs an online brokerage portal, Gewerbeversicherung24, to gather direct feedback from businesses, helping to refine and improve the services offered to its partners.
CareStack
Series B in 2019
CareStack is a company that provides an all-in-one cloud-based platform designed to streamline dental practice management. The platform integrates various functionalities including patient engagement, scheduling, telehealth conferencing, charting, automated reminders, claims and billing, and business insights. This comprehensive solution aims to enhance operational efficiency, improve patient care, and increase financial success for dental practices. CareStack's mission is to support dentists in achieving better practice management and an improved quality of life through its technology-driven offerings.
Insilico Medicine
Series B in 2019
Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.
Spendesk
Series B in 2019
Spendesk is an innovative expense management platform founded in 2016 that aims to streamline the spending process for businesses. It provides an all-in-one solution that includes features such as spend approvals, corporate cards, expense reimbursements, budget tracking, and invoice management, all designed to enhance visibility and automate financial workflows. This platform is particularly beneficial for finance teams, allowing them to save time and allocate resources toward more strategic initiatives. Trusted by a diverse range of organizations, from startups to established brands like Algolia and Soundcloud, Spendesk helps users focus on their core business operations rather than administrative tasks. Additionally, Spendesk supports a community of finance leaders through its initiative, CFO Connect, which has grown rapidly to include over 7,000 members.
Aperza
Series B in 2019
Aperza Inc. is a company based in Yokohama, Japan, established in 2016, that focuses on enhancing the manufacturing industry through digital solutions. It operates a suite of online platforms, including Aperza, an industrial portal, and Aperza Catalog, which serves as an industrial catalog portal. Additionally, Aperza provides an e-commerce marketplace tailored for industrial products, as well as various media outlets like Monozukuri News and Automation News Web. The company aims to remove barriers related to information, transactions, and communication within the manufacturing sector. By supporting manufacturers and startups in adapting to modern trends such as Industry 4.0 and IoT, Aperza seeks to contribute to the revitalization of Japan's core manufacturing industry and facilitate easier access to raw materials and products for engineers.
StashAway
Series B in 2019
StashAway Malaysia Sdn Bhd is a licensed investment platform that focuses on providing accessible wealth management solutions for individuals. It caters to both retail and accredited investors by offering personalized financial planning and portfolio management services. StashAway utilizes a risk-management investment strategy known as ERAA® (Economic Regime-based Asset Allocation) to maximize long-term returns while maintaining consistent risk exposure for clients through various economic conditions. The platform aims to simplify the investment process, making it approachable for users of all experience levels, and it emphasizes low fees to enhance affordability. Through its mobile app, StashAway equips investors with the tools and resources necessary to make informed decisions, thereby facilitating effective wealth management.
Nanos Medical
Series B in 2019
Nanos Medical specializes in the research, development, manufacturing, and sales of disposable medical devices, primarily targeting the cardiovascular and ear, nose, and throat (ENT) fields. The company offers a range of innovative products, including sinus balloon catheters, eustachian tube balloons, disposable nasopharyngeal airways, nasolacrimal balloons, and drug-eluting stents for sinus applications. Through its advanced medical devices, Nanos Medical aims to enhance treatment options for hospitals and patients, contributing to improved healthcare outcomes.
Whatfix
Series B in 2019
Whatfix is a company that specializes in providing a digital adoption platform designed to enhance user productivity and ensure process compliance across various applications. Their platform offers personalized, real-time guidance within applications, making it easier for users to navigate and complete tasks efficiently. This includes simulated application environments for training purposes and no-code application analytics. By leveraging generative AI, Whatfix helps companies improve the overall user experience, whether the applications are used internally or by customers. The platform aims to streamline learning and support processes, ultimately driving productivity gains and better decision-making through data-driven insights.
Beam Therapeutics
Series B in 2019
Beam Therapeutics Inc. is a biotechnology company based in Cambridge, Massachusetts, specializing in the development of precision genetic medicines utilizing its innovative base editing technology. Founded in 2017, the company aims to provide lifelong cures for patients suffering from serious diseases by targeting specific bases in the genome without inducing double-stranded breaks in DNA. Beam Therapeutics is actively developing therapies for a range of conditions, including sickle cell disease, beta-thalassemia, pediatric T-cell acute lymphoblastic leukemia, pediatric acute myeloid leukemia, alpha-1 antitrypsin deficiency, glycogen storage disorder type 1A, as well as ocular and central nervous system disorders. The company’s diverse pipeline includes several programs such as BEAM-101, BEAM-201, BEAM-301, BEAM-302, and ESCAPE, reflecting its commitment to advancing gene correction, gene modification, gene activation, gene silencing, and multiplex editing technologies.
LenoMed Medical
Series B in 2018
LenoMed Medical is a manufacturer of medical devices focused on improving diabetes management. With over 15 years of research and development experience in infusion technology, the company specializes in creating innovative products such as the InnoTech insulin pump, drug infusion pumps, and related disposables. LenoMed is dedicated to enhancing diabetes care through the integration of continuous glucose monitoring technology with their insulin pumps, aiming to provide patients with better treatment options and monitoring capabilities. Their commitment to advancing diabetes management is reflected in their comprehensive diabetes care management system.
JuLive.com
Series B in 2018
Julive is a new house transaction service platform.
Axoni
Series B in 2018
Axoni is a technology company that specializes in real-time data replication and distributed ledger software for the financial services industry. Founded in 2017, it serves major financial institutions, including banks, asset managers, hedge funds, and market infrastructure firms globally, with offices in New York and London. Axoni's platform facilitates the seamless integration of traditional financial technologies with blockchain systems, offering market information and deep analysis of trends. Its solutions enable rapid deployment of critical financial networks and automate real-time data sharing among market participants, enhancing the management of legal records, lifecycle events, and cash flow calculations.
Worktile Technology
Series B in 2018
Worktile Technology, established in 2013, is a Chinese software company headquartered in Beijing, with offices in Shanghai, Shenzhen, and Xi'an. It specializes in a web and mobile-based project management tool, designed to enhance team collaboration and productivity among developers and professionals. The platform facilitates task management, communication, and document sharing, aiming to streamline work processes and improve overall efficiency.
UWinTech
Series B in 2018
UWinTech is a comprehensive provider of IT operations and maintenance solutions, established in 2015 and headquartered in Shenzhen, China. The company specializes in application management services that encompass continuous delivery, continuous deployment, operation automation, and application monitoring. Its product offerings include EasyCMDB, Easydevops, Easyobserve, EasyMAbuilder, and Easyautoops. By delivering these integrated services, UWinTech aims to assist enterprises in streamlining their IT operations, thereby reducing operational efforts and enhancing productivity.
Moneybox
Series B in 2018
Moneybox is a mobile application that simplifies saving, investing, and pension management for individuals. It enables users to save specifically for their first home, making it particularly appealing for first-time buyers. The app allows users to round up spare change from everyday transactions, which can then be saved and invested, offering the potential for higher returns compared to traditional savings accounts. Moneybox provides a range of financial services, including personal savings accounts, investment products, and pension management, all designed to help individuals build wealth over time. The user-friendly interface of the app ensures that managing finances is accessible and straightforward.
Kyligence
Series B in 2018
Kyligence Inc. is a data intelligence company established in 2016 and headquartered in Shanghai, China. It specializes in providing an intelligent data platform designed to simplify big data analytics across both on-premises and cloud environments. The company’s primary offerings include the Kyligence Analytics Platform, which enables sub-second query responses on large datasets, and Apache Kylin, an open-source OLAP engine that facilitates interactive analytics on petabyte-scale data using SQL interfaces. Additionally, Kyligence provides a range of services such as intelligent diagnosis and optimization through its KyBot tool, along with IT consulting and website management solutions. By focusing on Big Data technologies and innovation, Kyligence aims to enhance productivity for business users, analysts, and engineers, enabling them to effectively manage and derive insights from extensive datasets.
Kongming
Series B in 2018
Kongming Inc. is a Beijing-based company established in 2010 that specializes in social media technology and marketing products. The firm offers a range of services including social monitoring tools, customer relationship management (CRM) solutions, social networking advertising, and data analysis. Kongming's focus is on enhancing interactions and relationships between businesses and their customers through effective use of social media platforms.
Fuse Universal
Series B in 2018
Fuse Universal, established in 2008, is a London-based company with offices in Sydney and Cape Town. It specializes in providing a social learning platform for large corporations, including FTSE 100 and Fortune 500 companies. The platform facilitates knowledge sharing, communication, and skill development via desktops and mobile devices. Fuse Universal serves over 150 global organizations, such as Hilti, Vodafone, and Panasonic, by fostering active engagement and deeper learning experiences through creativity and storytelling.
Red Points
Series B in 2018
Red Points is a technology company focused on protecting brands from online counterfeiting, digital piracy, and distribution fraud. Established in 2011 and headquartered in Barcelona, Spain, Red Points offers a software-as-a-service (SaaS) platform that employs machine learning and computer vision to identify and eliminate counterfeit products and pirated content across more than one hundred online marketplaces and social networks. The platform processes hundreds of thousands of infringement incidents each month, assisting over five hundred brands globally, including well-known names such as Bang & Olufsen, MVMT, and DOPE. By providing effective solutions for brand protection, Red Points helps companies safeguard their intellectual property in the digital landscape.
Tempest Therapeutics
Series B in 2018
Tempest Therapeutics Inc. is a biotechnology company based in South San Francisco, California, focused on developing small molecule therapeutics for cancer treatment. Established in 2011, the company aims to enhance anti-tumor immunity through its innovative drug pipeline, which includes clinical-stage candidates such as TPST-8844, TPST-1120, and TPST-1495. TPST-8844 targets an enzyme that helps tumor cells evade immune responses, while TPST-1120 blocks the PPAR-alpha pathway to stimulate immune effector cells essential for fighting tumors. Additionally, the company's therapeutics address pathways that directly kill tumor cells and activate tumor-specific immunity, positioning Tempest Therapeutics at the forefront of cancer treatment innovation.
Duco Technology
Series B in 2018
Duco Technology Limited is a data engineering company that specializes in providing cloud-based software for data matching, reconciliation, and transformation. Founded in 2006 and headquartered in London, Duco offers a self-service platform that enables financial institutions, including banks, asset managers, hedge funds, and brokers, to normalize, validate, and reconcile various types of data on demand. The company's flagship product, Duco Cube, addresses complex reconciliation challenges using advanced technology. With additional offices in New York, Wroclaw, Luxembourg, Edinburgh, and Singapore, Duco serves a global clientele, delivering innovative solutions that enhance data integrity, improve business agility, and ensure compliance with regulatory requirements. The company's SaaS platform integrates seamlessly with existing systems, minimizing disruption while providing actionable insights for its users.
Fibe
Series B in 2018
Fibe is a prominent consumer lending application in India, catering to the financial needs of young, aspirational, and tech-savvy individuals. The company has developed an online financial platform that specializes in providing ultra short-term loans and salary advances. Its services include small bridge loans that assist customers until their next salary credit, as well as small loans designed to help users navigate financial challenges at the end of the month. By offering accessible and timely financial solutions, Fibe aims to support users during critical times, making it a valuable resource for managing immediate credit needs.
Orient Speech Therapy
Series B in 2017
Orient Speech Therapy Center is a professional organization focused on enhancing children's speech and mental development. It specializes in providing speech and language therapy services for children with speech disorders, including those with autism. The center offers early screening, clinical diagnosis, and therapeutic interventions to support improved communication skills. To facilitate this development, Orient Speech Therapy has designed comprehensive curriculums, including the Star Curriculum, which targets children's speech, social skills, phonics, and oral muscle exercises. Through these tailored programs, the center aims to help children overcome communication challenges and foster their overall growth.
Candee
Series B in 2017
Candee Inc. is a Tokyo-based production company founded in 2015 that specializes in online video production and talent management. The company provides a range of services, including advertising, video editing, branding, content creation, public relations, and digital marketing. Through its online platform, Candee produces advertising and media videos, focusing particularly on mobile content, which allows businesses to effectively advertise and manage talent in the digital space.
Semma Therapeutics
Series B in 2017
Semma Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative cell therapies for patients with Type 1 diabetes. Founded in 2014, the company is dedicated to creating a transformative treatment that addresses the need for insulin injections by generating functional, insulin-producing beta cells through a proprietary method licensed from the laboratory of Professor Douglas Melton. Semma Therapeutics aims to combine these engineered cells with advanced devices to offer a potential replacement for the missing beta cells in diabetic patients, eliminating the need for immunosuppression. The company's ongoing research seeks to bring this novel therapeutic option to clinical settings, ultimately improving the lives of individuals living with diabetes.
Stockpile
Series B in 2017
Stockpile, Inc., founded in 2010 and headquartered in San Francisco, California, operates in the financial services sector, focusing on making investing accessible for young and first-time investors. The company provides a platform that simplifies the investment process, allowing users to open free accounts, purchase individual stocks, and set up automatic investment plans. Through features such as zero fee trading, custodial accounts, gift cards, and fractional investing, Stockpile enables individuals to invest in blue chip stocks without the high costs typically associated with these investments. The platform also includes educational resources, offering free mini-lessons to help users understand stock investing. Stockpile Investments, Inc. is a registered broker-dealer and a member of FINRA and SIPC, reflecting its commitment to regulatory compliance and investor protection. The company has garnered attention from prominent publications and maintains a high user rating on app stores.
Haici Technology
Series B in 2017
Haici Technology is a developer of a mobile platform aimed at enhancing the efficiency of hospital operations. The platform serves as a smart healthcare service solution, designed to improve patient visit experiences and reduce wait times. By integrating online and offline medical services, it facilitates better connections between hospitals and patients while also streamlining administrative workflows. The company's focus is on optimizing hospital visits and expanding the range of services offered, ultimately aiming to improve overall healthcare delivery.
Chai Point
Series B in 2017
Chai Point is a prominent beverage brand in India, specializing in the preparation and sale of high-quality chai made from fresh, natural ingredients. With a growing emphasis on coffee, the company offers a diverse menu that includes various hot and iced chai options, shakes, and complementary snacks such as multigrain biscuits and quinoa puffs. Operating in eight cities, Chai Point aims to transform tea consumption in India through its retail chain of tea stores, which prioritize quality and authenticity. Customers can conveniently order their favorite beverages online for delivery, enhancing accessibility and convenience in enjoying their chai rituals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.